1. Introduction {#sec1}
===============

Gestational diabetes mellitus (GDM) is one of the most common complications during pregnancy and is therefore a significant public health issue. The global prevalence of GDM remains unknown, as no systematical synthesized data is available \[[@B1]\], but GDM is estimated to affect 15\~20% of pregnancies \[[@B2]\]. GDM brings both short- and long-term threats to the health of mothers \[[@B3]\] and their children \[[@B4]\]. Nevertheless, the etiology of GDM is not fully understood, as only a few risk factors have been established, including advanced maternal age, obesity, and a family history of diabetes \[[@B5]\].

Vitamin D insufficiency and deficiency a global concern \[[@B6]\], especially for pregnant women \[[@B7]\], and the association between vitamin D levels and the GDM risk have received considerable research attention \[[@B8], [@B9]\]. The varied results from observational studies \[[@B10]\] and randomized trails \[[@B11]\] reveal that vitamin D concentrations are influenced by multiple factors and that the association between vitamin D levels and GDM is likely confounded by these factors. The most important factors are body mass index (BMI) and seasonality. BMI is a well-established risk factor for GDM \[[@B12]\] and being closely related to serum vitamin D concentrations \[[@B13]\]. Seasonality and vitamin D concentrations are also intuitively intertwined \[[@B13]\]. Some evidence suggests that seasonality is independently linked to glucose homeostasis in pregnancy \[[@B14]\]. The majority of existing observational studies have inadequately adjusted for these two factors, and only a few studies have simultaneously adjusted both BMI and seasonality, which has led to inconsistent results \[[@B8], [@B15]\]. Well-designed studies with a sample size that is large enough to evaluate these variables are desperately needed to determine whether pregnant women could benefit from vitamin D supplementation to reduce risk of GDM.

Genetic variants in vitamin D metabolic genes are good candidates to better understand how vitamin D pathways are involved in the pathogenesis of GDM. Several studies \[[@B16], [@B17]\] have contributed data to this subject. However, to our knowledge, no research to date has explored the interactions of variants in vitamin D metabolic genes with vitamin D concentration on the risk of GDM. Given these considerations, the current study used data from the Ma\'anshan birth cohort (MABC) study in China to explore both the independent effects and the interactions of vitamin D in early pregnancy and seven genetic variants on vitamin D metabolic genes on the risk of GDM.

2. Material and Methods {#sec2}
=======================

2.1. Study Population {#sec2.1}
---------------------

The Ma\'anshan birth cohort (MABC) study is a population-based prospective study conducted in Ma\'anshan city of Anhui province in China \[[@B18]\]. The MABC recruited 3 474 pregnant women at their first prenatal visit between May 2013 and September 2014. Participants were then followed until labor for a maximum of four times (the first, second, and third trimesters and delivery). Of these participants, 3 110 women who had both a diagnosis of GDM (or not) and vitamin D assessment during the first trimester were considered as candidates for the current study. To examine the specific associations between single nucleotide polymorphisms (SNPs) and the risk of GDM, 274 GDM cases and 380 age-matched controls were included (see [Figure 1](#fig1){ref-type="fig"} for a flow chart). The present study was approved by the ethics committee of Anhui Medical University. Written informed consent was obtained from all pregnant women.

2.2. Data Collection {#sec2.2}
--------------------

Extensive data were collected using a structured self-report questionnaire that was administered by trained interviewers at every visit. These data included age, race, education, socioeconomic status, smoking, alcohol consumption, and anthropometric measures. Information on multivitamin supplements was assessed for different periods (one month before pregnancy, first/second/third trimester of pregnancy). If supplement used was indicated, frequency (e.g., daily, weekly) was assessed.

2.3. GDM Diagnosis {#sec2.3}
------------------

At 24\~28 weeks of gestation, women were screened by a "one-step" standardized 75 g oral glucose tolerance test (OGTT) to diagnose GDM. Venous blood samples were collected at 0, 1, and 2 h after a glucose load, and a positive diagnosis of GDM was made when any of the following criteria were met: fasting plasma glucose at 0 h ≥5.1 mmol/l, at 1 h ≥10 mmol/l, and at 2 h ≥8.5 mmol/l \[[@B19]\].

2.4. Vitamin D Measurement {#sec2.4}
--------------------------

Blood sample was collected before 14 weeks of the first trimester. Fasting blood was drawn in the morning before 10 am and stored at -80 degrees. Serum 25-hydroxyvitamin D (25\[OH\] D) concentration, a vitamin D metabolite, was measured by radioimmunoassay (RIA) using a commercially available kit (DiaSorin, Stillwater, Minnesota 55082-0285, USA). Samples were randomly assayed and measured in a blinded manner. For quality control, standard substances of low (10.9\~23.3 ng/ml) and high (36.1\~76.5 ng/ml) concentrations were both determined using our method, which was proven to be reliable. The intra-assay and interassay coefficients of variation of 25\[OH\] D were both \<10%. All participants had 25\[OH\] D concentration above the detection limit (1.5 ng/ml).

2.5. SNP Selection and Genotyping {#sec2.5}
---------------------------------

By tracking the literature, we selected seven SNPs that are commonly reported in the vitamin D metabolism pathway for assessment. These SNPs included rs1544410 and rs731236 in the vitamin D receptor (VDR), rs2282679 and rs7041 in the vitamin D-binding protein (DBP), rs3829251 in 7-dehydrocholesterol reductase (DHCR7), rs6013897 in the cytochrome P450 family 24 subfamily A member 1 (CYP24A1), and rs6599638 in chromosome 10 open reading frame 88 (C10orf88). Genotyping of candidate SNPs was conducted by the improved multiple ligase detection reaction (iMLDR), with technical support from the Center for Human Genetics Research, Shanghai Genesky Biotechnology Company. For quality control, 5% of duplicate samples were independently reanalyzed in a blinded manner. SNPs that violated the Hardy-Weinberg equilibrium (HWE) in controls would be removed from the analysis. The call rate of these SNPs was required to be over 90%.

2.6. Statistical Analysis {#sec2.6}
-------------------------

Prepregnancy body mass index (BMI) was categorized into four groups: \<18.5, 18.5\~24, 24\~28, and ≥28 \[[@B20]\]. Vitamin D concentrations were classified into three categories: deficiency, 25\[OH\] D \<20 ng/ml; insufficiency, 25\[OH\] D 20\~30 ng/ml; and normal/optimal, 25\[OH\] D \>30 ng/ml. Smoking at early pregnancy was defined as either ongoing smoking or former smoker who quit after knowing about pregnancy. Alcohol drinking was categorized as never, occasional, and regular. Multivitamin supplement intake frequency was categorized as never, 1\~2 times/week, 3\~6 times/week, and every day. Education level was categorized into five groups: primary school or below, middle school, high school, junior college, and undergraduate or above. Monthly income levels (Chinese yuan) were divided into four groups: \<1000, 1000\~2500, 2500\~4000, and ≥4000. The Northern Hemisphere seasons were defined as spring (February to April), summer (May to July), fall (August to October), and winter (November to January).

To examine the group differences, the chi-square test was used for categorical variables, whereas either Student\'s *t*-test or ANOVA was used for continuous variables. Effect estimates for vitamin D deficiency, conception season, and genetic variants alone and in combination, as risk factors for GDM, were evaluated using multivariate logistic regression. The most complete model included potential confounders such as age, prepregnancy BMI, family diabetes history, parity and smoking at early pregnancy, drinking status, gestational week, education, and income. Stratified analyses of vitamin D concentrations were conducted according to different genotypes. The probability value for interactions between SNPs and vitamin D was calculated by a pair-wise analysis under the multiplicative interaction model which was evaluated by a likelihood ratio test in the logistic regression.

Analyses were conducted using SPSS v16.0, and statistical significance was set at *P* \< 0.05.

3. Results {#sec3}
==========

Among the full sample of 3 110 women, we documented 399 cases of GDM. [Table 1](#tab1){ref-type="table"} shows the characteristics of total participants and different characteristics according to GDM status. GDM cases were more likely to have higher prepregnancy BMI, advanced age, family history of type 2 diabetes, a conception season of summer, and higher vitamin D concentrations.

The highest vitamin D concentrations were seen in pregnancies with summer conception; the lowest occurred in winter. Multivitamin intake in early pregnancy was associated with increased vitamin D concentration in the first trimester. The factors of gestational weeks, parity, prepregnancy BMI, education, and smoking status in early pregnancy also influenced its concentrations (see Supplementary Tables [1](#supplementary-material-1){ref-type="supplementary-material"} and [2](#supplementary-material-1){ref-type="supplementary-material"}).

[Table 2](#tab2){ref-type="table"} shows the effect sizes of vitamin D concentration in the first trimester and conception season on the risk of GDM, based on logistic regression analysis. Vitamin D deficiency was associated with a decreased risk of GDM relative to normal vitamin D concentrations. However, when the model was adjusted for conception season (OR = 0.79, 95% CI = 0.55-1.13) or season of the blood draw (OR = 0.78, 95% CI = 0.54-1.11), the association became nonsignificant. In the most adjusted model, conception in fall-winter had a 37% decreased risk of GDM (OR = 0.63, 95% CI = 0.49-0.81), independent of vitamin D concentrations, compared with spring-summer (see Supplementary [Table 3](#supplementary-material-1){ref-type="supplementary-material"}).

[Table 3](#tab3){ref-type="table"} indicates that both SNPs rs1544410 and rs731236 in VDR were significantly associated with the risk of GDM. Compared with rs1544410-CC genotypes, individuals who carried CT genotypes had an increased risk of GDM (OR = 2.03, 95% CI = 1.17-3.51). Compared with rs731236-AA genotypes, individuals who carried GA genotypes had an increased risk of GDM (OR = 2.42, 95% CI = 1.29-4.55). Supplementary [Table 3](#supplementary-material-1){ref-type="supplementary-material"} presents the stratified analysis of the association of vitamin D concentrations with the risk of GDM according to different SNP genotypes. No significant interactions were detected between SNPs and vitamin D concentrations, with respect to the risk of GDM.

4. Discussion {#sec4}
=============

The current large prospective cohort study indicated that vitamin D concentrations in early pregnancy are not independently associated with the risk of GDM but are confounded by seasonality. The conception season of fall-winter was significantly associated with a decreased risk of GDM independent of vitamin D concentration. Furthermore, the current study demonstrated significant associations of the two SNPs rs1544410 and rs731236 in the VDR gene with the risk of GDM.

The large sample size of our study enabled us a comprehensive evaluation of vitamin D status among pregnant women. Consistent with other research \[[@B7]--[@B9]\], a high rate of vitamin D deficiency and insufficiency was observed. Vitamin D concentrations also demonstrated expected relationships with season and multivitamin supplement intake. In contrast with other research which supports an association between higher BMI and lower vitamin D \[[@B21]\], this study found a relatively small positive association between vitamin D concentration and prepregnancy BMI. This result was consistent with the studies conducted in China \[[@B22]\] and in the Czech Republic \[[@B23]\]. Moreover, smoking in the early pregnancy exerted a negative effect on vitamin D concentration, and its effect size was the largest among all studied factors.

We did not find that vitamin D concentrations in early pregnancy were significantly associated with the risk of GDM, but conception season was. Vitamin D concentrations and the risk of GDM have been controversial, in part as the results from observational studies and randomized controlled trials have been inconsistent. Vitamin D concentrations and the risk of GDM are influenced by multiple shared factors, so controlling confounding variables might be the priority to guarantee reliability. Unfortunately, previous studies have typically had obvious confounding factors such as seasonality. The current study was large enough and had sufficient measurement of constructs to suggest that higher vitamin D concentrations had a simple association with an increased risk of GDM; the association vanished after adding conception season to the model. This result is supported by many studies \[[@B24]--[@B27]\], especially those that have controlled for seasonality \[[@B26], [@B27]\]. While the current results are supported by large sample size and many aspects of measurement, the study did adopt a common definition for vitamin D insufficiency and deficiency. There are other definitions, however, such as the more conservative definition adopted by the Institute of Medicine, which uses the following categorization system: \<12 ng/ml is "risk of deficiency," 12\~20 ng/ml is "risk of inadequacy," and \>20 ng/ml is "sufficiency" \[[@B28]\]. The interpretation of the current study should bear in mind alternative models of classification.

The seasonality and risk/prevalence of GDM have become an emerging research interest lately \[[@B29]--[@B32]\]. This is the first study that revealed that the association between vitamin D concentrations and the risk of GDM might partly be confounded by seasonality and in particular that summer conception (in the Northern Hemisphere) increases the risk of GDM independent of vitamin D concentration and other potential confounders. The mechanism behind this association remains unclear. One potential mechanism is that there may be other third variables or modifiers related to the season, such as physical activity \[[@B33]\] or air pollution \[[@B34]\], however, in our study that might not be the case. A second possibility relates to circannual rhythms. For example, the duration of the peak of melatonin secretion is positively correlated with the length of the night period \[[@B35]\], and there is evidence that lowering the melatonin is associated with higher risk of diabetes \[[@B36]\]. Summer nights are much shorter than in winter, so summer conception could increase the risk of GDM. However, our result was opposite to some other studies \[[@B30], [@B31]\] which showed that winter conception was a risk factor to GDM. The current results are consistent with a study conducted in the UK which found that type 1 diabetes was more frequently diagnosed in winter \[[@B37]\]. These conflicting results suggest a complicated mechanism between seasonality and GDM and warrant further exploration.

Genetic background inspection could provide novel information about the vitamin D metabolic pathway in the pathogenesis of GDM. Two SNPs in the VDR gene were found in the current study to be correlated with an increased risk of GDM. VDR gene encodes vitamin D3 receptor, which is a member of the nuclear hormone receptor superfamily and mediates the actions of vitamin D \[[@B38]\]. SNPs on this gene have been extensively studied \[[@B39]\] and are widely associated with a variety of metabolic phenotypes \[[@B40]--[@B42]\]. Among these SNPs, rs1544410 and rs731236 were commonly reported as significant, especially as they influence insulin resistance-related diseases \[[@B43]\]. Rs1544410 is an intron variant, and rs731236 is a synonymous variant, while the minor allele frequency (MAF) of both two SNPs varies across different races and ethnic groups, with lowest among East Asian to highest among European, which could partly explain the inconsistency across the diverse population. In our study, for rs1544410 and rs731236, different genotypes have marginal differences in vitamin D concentrations but they are significantly associated with the risk of GDM. However, for the two other SNPs of rs2282679 and rs6599638, the pattern is reversed. Based on these data, it was speculated that the relationships among the VDR variants and vitamin D concentrations would not necessarily explain the associations between the VDR variants and the risk of GDM. The association of the VDR variants with vitamin D concentration can instead be a marker of the (unclear) effects of the variants that modify the risk of GDM. The current lack of significant interactions between vitamin D concentrations and genetic variants supports the idea that genetic variants might be more important than vitamin D concentrations when considering vitamin D metabolic pathways involved in GDM, and our results are entirely supported by another study on a similar topic about type 1 diabetes \[[@B44]\].

The current study has several notable strengths. It had a large sample size which permitted the consideration of several critical and simultaneous potential confounders. Second, the study was able to evaluate both the independent role of vitamin D concentrations and interactions with SNPs in vitamin D metabolic gene as risk factor for GDM. Despite these advantages, limitations of the study include lack of information on diet, physical activity, and the assessment of a limited number of SNPs. Also, the vast majority of the current sample was Han Chinese, which limits the study\'s generalizability.

In conclusion, this study did not find that early pregnancy vitamin D insufficiency or deficiency was significantly associated with the risk of GDM. Instead, the current results emphasize the importance of genetic variants in VDR and conception season as risk factors for GDM. Although the current study contributes to the understanding of vitamin D metabolic pathway in the occurrence of GDM, other well-designed studies are needed to replicate and extend these results.
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![Flow chart of participant inclusion and exclusion of our study.](JDR2019-8313901.001){#fig1}

###### 

Characteristics of women included for investigating the association of vitamin D concentrations and the risk of GDM.

  Variables                                    Total         Non-GDM (*N* = 2711)   GDM (*N* = 399)   *P*
  -------------------------------------------- ------------- ---------------------- ----------------- --------------
  *Age*                                        26.7 ± 3.7    26.5 ± 3.5             28.1 ± 4.4        **\<0.001**
                                                                                                      **\<0.001**
  \<25                                         910 (29.3)    832 (30.7)             78 (19.5)         
  25\~30                                       1634 (52.5)   1438 (53.0)            196 (49.1)        
  30\~35                                       434 (14.0)    351 (12.9)             83 (20.8)         
  ≥35                                          132 (4.2)     90 (3.3)               42 (10.5)         
  *Prepregnancy BMI*                           20.9 ± 2.8    20.7 ± 2.7             22.3 ± 3.2        **\<0.001**
                                                                                                      **\<0.001**
  \<18.5                                       577 (18.6)    545 (20.1)             32 (8.0)          
  18.5\~24                                     2154 (69.3)   1882 (69.4)            272 (68.2)        
  24\~28                                       306 (9.8)     234 (8.6)              72 (18.0)         
  ≥28                                          72 (2.3)      49 (1.8)               23 (5.8)          
  *Gender of infant*                                                                                  0.797
  Male                                         1563 (50.3)   1367 (50.4)            196 (49.1)        
  Female                                       1502 (48.3)   1309 (48.3)            193 (48.4)        
  Unknown                                      45 (1.4)      35 (1.3)               10 (2.5)          
  *Parity*                                                                                            **0.003**
  Nulliparous                                  2751 (88.5)   2416 (89.1)            335 (84.0)        
  Multiparous                                  359 (11.5)    295 (10.9)             64 (16.0)         
  *Education*                                                                                         0.554
  Primary school or below                      39 (1.3)      33 (1.2)               6 (1.5)           
  Middle school                                595 (19.1)    507 (18.7)             88 (22.1)         
  High school                                  699 (22.5)    611 (22.5)             88 (22.1)         
  Junior college                               964 (31.0)    844 (31.1)             120 (30.1)        
  Undergraduate or above                       813 (26.1)    716 (26.4)             97 (24.3)         
  *Monthly income (Chinese yuan)*                                                                     0.087
  \<1000                                       53 (1.7)      45 (1.7)               8 (2.0)           
  1000\~2500                                   771 (24.8)    655 (24.2)             116 (29.1)        
  2500\~4000                                   1338 (43.0)   1167 (43.0)            171 (42.9)        
  \>4000                                       948 (30.5)    844 (31.1)             104 (26.1)        
  *Smoking in early pregnancy*                                                                        0.670
  No                                           2982 (95.9)   2601 (95.9)            381 (95.5)        
  Yes                                          128 (4.1)     110 (4.1)              18 (4.5)          
  *Drinking*                                                                                          0.764
  Never                                        2865 (92.1)   2495 (92.0)            370 (92.7)        
  Occasionally                                 240 (7.7)     212 (7.8)              28 (7.0)          
  Regularly                                    5 (0.2)       4 (0.1)                1 (0.3)           
  *Family history of diabetes*                                                                        **\<0.001**
  No                                           2439 (78.4)   2155 (79.5)            284 (71.2)        
  Yes                                          255 (8.2)     198 (7.3)              57 (14.3)         
  Uncertain                                    416 (13.4)    358 (13.2)             58 (14.5)         
  *Gestational weeks in the 1^st^ trimester*   10.0 ± 2.1    10.1 ± 2.2             10.0 ± 2.0        0.660
  *Season of conception*                                                                              **\<0.001**
  Spring                                       929 (29.9)    793 (29.3)             136 (34.1)        
  Summer                                       916 (29.5)    773 (28.5)             143 (35.8)        
  Fall                                         643 (20.7)    581 (21.4)             62 (15.5)         
  Winter                                       622 (20.0)    564 (20.8)             58 (14.5)         
  *Season in the 1^st^ trimester*                                                                     **\< 0.001**
  Spring                                       713 (22.9)    630 (23.2)             83 (20.8)         
  Summer                                       1187 (38.2)   998 (36.8)             189 (47.4)        
  Autumn                                       549 (17.7)    482 (17.8)             67 (16.8)         
  Winter                                       661 (21.3)    601 (22.2)             60 (15.0)         
  *Serum 25\[OH\] D*                           18.2 ± 8.4    18.0 ± 8.4             19.8 ± 8.3        **\<0.001**
                                                                                                      **0.002**
  Deficiency                                   2052 (66.0)   1819 (67.1)            233 (58.4)        
  Insufficiency                                747 (24.0)    635 (23.4)             112 (28.1)        
  Normal                                       311 (10.0)    257 (9.5)              54 (13.5)         
  *Fasting glucose*                            4.3 ± 0.6     4.2 ± 0.4              5.0 ± 0.7         **\<0.001**
  *1 h glucose load*                           7.2 ± 1.8     6.8 ± 1.4              9.6 ± 2.0         **\<0.001**
  *2 h glucose load*                           6.1 ± 1.3     5.9 ± 1.0              7.7 ± 1.9         **\<0.001**

Abbreviation: BMI, body mass index.

###### 

The association between vitamin D concentration in the first trimester, conception season, and risk of GDM.

  Variable              Crude OR (95% CI)      Adjusted OR1 (95% CI)   Adjusted OR2 (95% CI)   Adjusted OR3 (95% CI)
  --------------------- ---------------------- ----------------------- ----------------------- -----------------------
  *Vitamin D*                                                                                  
  Normal                1.00                   1.00                    1.00                    1.00
  Insufficiency         0.84 (0.59-1.20)       0.86 (0.59-1.26)        0.88 (0.60-1.29)        0.87 (0.55-1.27)
  Deficiency            **0.61 (0.44-0.84)**   **0.69 (0.49-0.98)**    0.79 (0.55-1.13)        0.78 (0.54-1.11)
  *Conception season*                                                                          
  Spring-summer         1.00                   1.00                    1.00                    ---
  Fall-winter           **0.59 (0.47-0.74)**   **0.61 (0.48-0.77)**    **0.63 (0.49-0.81)**    ---

Adjusted OR1 for vitamin D is adjusted for age, prepregnancy BMI, family history of diabetes, parity, smoking, drinking, gestational week of blood withdrawn, income, and education; adjusted OR1 for conception season is adjusted for age, prepregnancy BMI, family history of diabetes, parity, smoking, drinking, income, and education; adjusted OR2 for vitamin D is adjusted OR1 plus adjusting for conception season (as four categories); adjusted OR2 for conception season was adjusted OR1 plus adjusting for vitamin D (as three categories). Adjusted OR3 is adjusted OR1 plus the season of the blood draw (as four categories) in the first trimester. Abbreviations: BMI: body mass index; OR: odds ratio; CI: confidence interval.

###### 

The association between SNPs in vitamin D metabolism genes and the risk of GDM.

  SNPs          Gene       Controls/cases   *P* ^∗^     Vitamin D       *P* ^†^     Crude OR (95% CI)   Adjusted OR (95% CI)
  ------------- ---------- ---------------- ----------- --------------- ----------- ------------------- ----------------------
  *rs1544410*   VDR                         **0.021**                   0.067                           
  CC                       353/240                      19.35 ± 8.72                1.00                1.00
  CT                       27/34                        17.09 ± 8.52                1.85 (1.09-3.15)    2.03 (1.17-3.51)
  *rs731236*    VDR                         **0.006**                   0.059                           
  AA                       341/237                      19.45 ± 8.78                1.00                1.00
  GA                       18/29                        16.72 ± 7.47                2.32 (1.26-4.28)    2.42 (1.29-4.55)
  *rs7041*      GC                          0.226                       0.063                           
  AA                       170/107                      18.16 ± 8.24                1.00                1.00
  CA                       158/133                      19.70 ± 8.64                1.34 (0.96-1.87)    1.34 (0.94-1.90)
  CC                       24/19                        20.57 ± 10.56               1.26 (0.66-2.41)    1.28 (0.65-2.52)
  *rs2282679*   GC                          0.890                       **0.002**                       
  TT                       167/127                      20.34 ± 9.23                1.00                1.00
  GT                       164/116                      18.05 ± 7.84                0.93 (0.67-1.30)    0.89 (0.63-1.25)
  GG                       32/25                        17.16 ± 8.04                1.03 (0.58-1.82)    1.06 (0.59-1.91)
  *rs3829251*   DHCR7                       0.834                       0.399                           
  GG                       157/106                      18.75 ± 8.82                1.00                1.00
  GA                       179/132                      19.25 ± 8.39                1.09 (0.78-1.53)    1.06 (0.75-1.51)
  AA                       23/18                        20.77 ± 11.10               1.16 (0.60-2.25)    1.23 (0.61-2.46)
  *rs6013897*   CYP24A1                     0.306                       0.462                           
  TT                       268/193                      19.36 ± 9.06                1.00                1.00
  AT                       105/69                       18.42 ± 7.68                0.91 (0.64-1.30)    0.91 (0.63-1.32)
  AA                       6/9                          20.22 ± 9.91                2.08 (0.73-5.95)    2.25 (0.76-6.65)
  *rs6599638*   C10orf88                    0.409                       **0.020**                       
  GG                       87/65                        19.77 ± 8.55                1.00                1.00
  GA                       179/147                      19.37 ± 8.93                1.10 (0.75-1.62)    1.07 (0.71-1.60)
  AA                       88/55                        17.16 ± 7.89                0.84 (0.53-1.33)    0.79 (0.49-1.28)

Adjusted OR is adjusted for age, prepregnancy BMI, family history of diabetes, parity, smoking, drinking, income, education, and conception season. Abbreviations: BMI: body mass index; OR: odds ratio; CI: confidence interval. ^∗^ *P* for the chi-square test. ^†^ *P* for Student\'s *t*-test/ANOVA
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